Mycobacterium goodii infections associated with surgical implants at Colorado Hospital

Emerging Infectious Diseases

Volumn 10, Issue 10, 2004, Pages 1868-1871

  Ferguson, Dayna Devon ^a,b,c   Gershman, Ken ^a   Jensen, Bette ^b   Arduino, Matthew J ^b   Yakrus, Mitchell A ^b   Cooksey, Robert C ^b   Srinivasan, Arjun ^b  

^a CO Dept of Pub Hlth and Environ ^*  (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CO Dept of Pub Hlth and Environ ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFALEXIN; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CASE REPORT; CLINICAL FEATURE; COXITIS; DEBRIDEMENT; DEVICE REMOVAL; DISEASE ASSOCIATION; EPIDEMIC; FEMALE; HERNIOPLASTY; HOSPITAL; HOSPITAL INFECTION; HUMAN; IMPLANT; IMPLANTATION; INGUINAL HERNIA; LABORATORY TEST; LAMINECTOMY; MALE; MYCOBACTERIUM; MYCOBACTERIUM GOODII; PROSTHESIS INFECTION; PROSTHESIS LOOSENING; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; WOUND DRAINAGE; WOUND INFECTION;

EID: 4844226886     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1010.040402     Document Type: Article

References (14)

1. Brown BA, Springer B, Steingrube VA, Wilson RW, Pfyffer GE, Garcia MJ, et al. Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol. 1999;49:1493-511.
2. Brown BA, Wallace RJ. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev. 2002;15:716-46.
3. Friedman ND, Sexton DJ. Bursitis due to Mycobacterium goodii, a recently described, rapidly growing mycobacterium. J Clin Microbiol. 2001;39:404-5.
4. NCCLS. Susceptibility testing of mycobacteria, Nocardiae, and other aerobic actinomycetes: Approved standards. NCCLS document M24-A. Wayne (PA): NCCLS; 2003.
5. Hector JS, Pang Y, Mazurek GH, Zhang Y, Brown BA, Wallace RJ. Large restriction fragment patterns of genomic Mycobacterium fortuitum DNA as strain-specific markers and their use in epidemiologic investigation of four nosocomial outbreaks. J Clin Microbiol. 1992;30:1250-5.
6. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-9.
7. Wallace JR, Zhang Y, Brown BA, Fraser V, Mazurek GH, Maloney S. DNA large restriction fragment patterns of sporadic and epidemic nosocomial strains of Mycobacterium chelonae and Mycobacterium abscessus. J Clin Microbiol. 1993;31:2697-701.
8. Wenger PN, Brown JM, McNeil MM, Jarvis WR. Nocardia farcinica sternotomy site infections in patients following open heart surgery. J Infect Dis. 1998;178:1539-43.
9. Wallace RJ, Brown BA, Griffith DE. Nosocomial outbreaks/pseudooutbreaks caused by nontuberculous mycobacteria. Annu Rev Microbiol. 1998;52:453-90.
10. Carson LA, Bland LA, Cusick LB, Favero MS, Bolan GA, Reingold AL, et al. Prevalence of nontuberculous mycobacteria in water supplies of hemodialysis centers. Appl Environ Microbiol. 1988;54:3122-5.
11. Camargo D, Saad C, Ruiz F, Ramirez ME, Lineros M, Rodriguez G, et al. Iatrogenic outbreak of M. chelonae skin abscesses. Epidemiol Infect. 1996;117:113-9.
12. Collins FM. Bactericidal activity of alkaline gluteraldehyde solution against a number of atypical mycobacterial species. J Appl Bacteriol. 1986;61:247-51.
13. Best M, Sattar SA, Springthorpe VS, Kennedy ME. Comparative mycobactericidal efficacy of chemical disinfectants in suspension and carrier tests. Appl Environ Microbiol. 1988;54:2856-8.
14. Best M, Sattar SA, Springthorpe VS, Kennedy ME. Efficacies of selected disinfectants against Mycobacterium tuberculosis. J Clin Microbiol. 1990;28:2234-9.